US Patent Issued to Sanegene Bio USA on Nov. 11 for "1'-alkyl modified ribose derivatives and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,647, issued on Nov. 11, was assigned to Sanegene Bio USA Inc. (Woburn, Mass.).

"1'-alkyl modified ribose derivatives and methods of use" was invented by Weimin Wang (Cambridge, Mass.) and Xiaochuan Cai (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides linker compounds of Formula (I) or (II):pharmaceutically acceptable salts thereof, and related scaffolds and conjugates. The present disclosure also relates to uses of the linker compounds, scaffolds, and conjugates, e.g., in delivering nucleic acid and/or treating or preventing diseases."

The patent was filed on Aug. 5, 2022, under Application No. 17/881...